Document is current
Any future updates will be listed below
-
Authors
Uzawa, Akiyuki https://orcid.org/0000-0001-9252-1863
Suzuki, Shigeaki
Kuwabara, Satoshi
Akamine, Hiroyuki
Onishi, Yosuke
Yasuda, Manato
Ozawa, Yukiko
Kawaguchi, Naoki
Kubota, Tomoya
Takahashi, Masanori P.
Suzuki, Yasushi
Watanabe, Genya
Kimura, Takashi
Sugimoto, Takamichi
Samukawa, Makoto
Minami, Naoya
Masuda, Masayuki
Konno, Shingo
Nagane, Yuriko
Utsugisawa, Kimiaki
-
Funding
Funding for this research was provided by:
Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan (20FC1030)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-022-01335-3
Content Type: article
Copyright: Copyright © 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.
